#ISSLS
📃Scientific paper: ISSLS Prize in Bioengineering Science 2023: Age- and sex-related differences in lumbar intervertebra...

➡️ Continued on ES/IODE

April 1, 2024 at 2:43 PM
The International Society for the Study of the Lumbar Spine #ISSLS is pleased to announce that the European Spine Journal #ESJ is now the official journal of ISSLS!
January 18, 2026 at 10:22 AM
📣 One week left to submit your abstract ‼️

The abstract deadline for the combined #ISSLS & #SASS 2026 Annual Meeting in Cape Town, South Africa (May 11–15, 2026) has been extended until November 15, 2025 ‼️

issls2026.org/abstracts/

#ISSLS2026 #CapeTown #SpineResearch
Abstracts - ISSLS/SASS Annual Meeting 2026
issls2026.org
November 7, 2025 at 9:36 AM
Why join ISSLS?
✔️ Discounted registration
✔️ Access to a truly interdisciplinary, international network
✔️ Eligibility for fellowships, awards, and committee roles
✔️ Voting rights to help shape the future of ISSLS
✔️ Opportunities to contribute to global initiatives, taskforces, and consensus papers
September 9, 2025 at 10:39 AM
ISSLS membership applications are now open until the 19th of September!

Join our global community of world-class spine researchers, clinicians, surgeons, and more before the deadline closes

📅 Deadline to apply: September 19th
🔗 Learn more and apply: www.issls.org/membership

Why join ISSLS? 👇🏼
MEMBERSHIP APPLICATION — The International Society for the Study of the Lumbar Spine
www.issls.org
September 9, 2025 at 10:39 AM
Let’s give a warm welcome to Dr. Mengis! 🫴

💬 Say hi in the comments & connect on LinkedIn:
🔗 www.linkedin.com/in/tamara-me...

Are you also pushing the boundaries of #LumbarSpine research? Join ISSLS and be part of a global community shaping the future of spine science:
🔗 www.issls.org/membership
www.linkedin.com
July 21, 2025 at 12:17 PM
🌟 Welcome Dr. Tamara Mengis – Our Newest ISSLS Member! 🌟

We’re excited to welcome Dr. Tamara Mengis, PhD to the #ISSLS community of spine researchers and clinicians!
July 21, 2025 at 12:17 PM
In this randomized controlled trial, the team investigated the use of autologous bone marrow-derived mesenchymal stromal cells BM- #MSCs to treat patients with chronic low back pain #LBP linked to multilevel intervertebral disc degeneration (IDD).

issls-2025.p.asnevents.com.au/days/2025-05...
Oral Presentation — ASN Events
issls-2025.p.asnevents.com.au
July 21, 2025 at 12:13 PM
🎉 Congratulations to the 2025 ISSLS Best Paper Award Winner! 🎉

We are thrilled to spotlight some of the most compelling research in #LumbarSpine science and clinical innovation.

This year’s Best Paper Award was to Prof. Gianluca Vadalà et al of the Università Campus Bio-Medico di Roma
July 21, 2025 at 12:13 PM
We’re already halfway through ISSLS 2025! 😲

From cutting-edge research to truly inspiring discussions, the energy here is amazing. #ISSLS2025
May 15, 2025 at 3:56 PM
Preoperative #SleepDisturbances and #Depression independently and jointly predict higher disability and pain 12 months after lumbar #SpineSurgery.​

The latest publication in Spine by #ISSLS member Kristin R. Archer and team: journals.lww.com/spinejournal...
The Combined Influence of Sleep Disturbance and Depression... : Spine
havioral factors are considered major risk factors for poor outcomes after LSS. However, there is a need to explore the combined effects of preoperative factors such as sleep disturbance and depressio...
journals.lww.com
April 10, 2025 at 6:49 AM
🌟 Introducing Dr. Shota Tamagawa – Our Newest ISSLS Member! 🌟

ISSLS is thrilled to welcome Shota Tamagawa, MD, PhD, Assistant Professor at Juntendo University Faculty of Medicine, Tokyo, Japan, to our #ISSLS community of spine researchers and clinicians!
April 10, 2025 at 6:44 AM
🌟 Welcome Dr. Jacopo Vitale – Our Newest ISSLS Member! 🌟

Dr. Vitale is a Research Associate at the Spine Centre at Schulthess Klinik in Zürich (Switzerland) and Associate Professor at the Institute of Sports Sciences at University of Physical Culture in Cracow (Poland).
April 10, 2025 at 6:40 AM
Publication in #ScienceAdvances by #ISSLS member Prof. Lisbet Haglund: www.science.org/doi/full/10.... This study investigates the potential of two senolytic drugs in treating #LowBackPain by targeting senescent cells, which accumulate with aging and contribute to #inflammation and degeneration
Senolytic treatment for low back pain
Senolytics drugs can reduce back pain by removing senescent cells from the intervertebral discs and spinal cord.
www.science.org
April 10, 2025 at 6:33 AM
📢 Publication in FASEB J by #ISSLS member Dr. Lachlan Smith et al highlights key findings using single cell RNA seq., revealing the diversity & crucial roles of notochord-derived NP cells in the postnatal mouse disc #SpineResearch #LumbarSpine #LowBackPain #RegenerativeMedicine #Biotechnology Link 👇🏼
March 19, 2025 at 12:15 PM
The #ISSLS Phenotype/Precision Spine Focus Group is driving advancements in low back pain management through predictive biomarkers. Their 2024 recommendations, now published in the European Spine Journal, emphasize unified terminology, robust research designs, and overcoming development barriers 👇🏼
Development and application of predictive clinical biomarkers for low back pain care: recommendations from the ISSLS phenotype/precision spine focus group - European Spine Journal
Predictive biomarkers (or moderators of treatment) are features, or more likely feature clusters, that discriminate individuals who are more likely to experience a favourable or unfavourable effect fr...
link.springer.com
March 11, 2025 at 12:26 PM
Meet Clara Ruiz Fernández who joined ISSLS because of the great collaborative environment between basic researchers and clinicians. As as a postdoctoral researcher at the the Tokai University School of Medicine, Clara is a key member of the #ISSLS Social Media Committee!
March 11, 2025 at 12:23 PM
Next to be introduced is Chantal Voskamp PhD, a postdoctoral researcher at the Utrecht University (Netherlands) whose research focuses on intervertebral disc regeneration using biomolecules derived from notochordal cells. Most importantly Chantal is a member of the #ISSLS Social Media Committee!
March 11, 2025 at 12:23 PM
Terence McSweeney, MSc is a doctoral researcher at the University of Oulu and #ISSLS SoMe member. His advice for (fellow) young researchers: take a few risks and go out of your comfort zone whether that's by promoting your work, networking, learning a new skill, or tackling a new topic.
March 11, 2025 at 12:23 PM
📢 New study by #ISSLS member Dr. Kakutani reveals TRPV4 knockdown impairs ECM synthesis via autophagy suppression, leading to disc degeneration in rats. Underscores autophagy's role in disc health, suggesting TRPV4 as a target for new therapies #SpineResearch onlinelibrary.wiley.com/doi/10.1002/...
Transient Receptor Potential Vanilloid 4 Knockdown Decreases Extracellular Matrix Synthesis via Autophagy Suppression in the Rat Intervertebral Disc
We conducted in vitro and in vivo TRPV4 RNA interference study in the rat intervertebral disc cells and tissues. In vitro, TRPV4 knockdown decreased extracellular matrix synthesis, cell viability, an...
onlinelibrary.wiley.com
March 11, 2025 at 12:10 PM
🚨 Perioperative spinal cord injury in high-risk adult deformity surgery is rare but devastating. The latest study in Spinal Cord Series & Cases by #ISSLS members Fan Jiang & colleagues examines its incidence, causes, outcomes, and management strategies. 🧠🔍 Full paper: www.nature.com/articles/s41...
Spinal cord injury in high-risk complex adult spinal deformity surgery: review of incidence and outcomes from the Scoli-RISK-1 study - Spinal Cord Series and Cases
Spinal Cord Series and Cases - Spinal cord injury in high-risk complex adult spinal deformity surgery: review of incidence and outcomes from the Scoli-RISK-1 study
www.nature.com
March 11, 2025 at 12:05 PM
📢 Check out the work of #ISSLS member Svenja Illien-Junger et al. in #JORSpine on PHLPP1’s role in IVD degeneration & small molecule inhibitors. Full study 👉 onlinelibrary.wiley.com/doi/10.1002/...

#SpineResearch
Differential efficacy of two small molecule PHLPP inhibitors to promote nucleus Pulposus cell health
Pharmacological inhibition of PHLPP via NSC45586 promotes nucleus pulposus cell health. NSC45586 is a potential drug candidate in treating IVD degeneration.
onlinelibrary.wiley.com
March 6, 2025 at 7:56 AM
Next let's introduce Luca Ambrosio, MD

As an Orthopaedic Surgeon and PhD student at Università Campus Bio-Medico di Roma, Luca is a valued member of the #ISSLS Social Media Committee. We had the chance to learn more about his journey in #SpineResearch and #ISSLS. Here's a quick Q&A!
February 14, 2025 at 10:52 AM
Today is the last change to apply for a travel grant to ISSLS
Eligibility 🎯:
🔹 First-time ISSLS in-person attendee
🔹 First/presenting author on an accepted abstract
🔹 Graduate student or within 4 years post-qualification (or under 40 as an independent researcher)
www.isslsmeetings.org/travel-grant
February 14, 2025 at 10:48 AM